Revelation Biosciences Warrant (REVBW) Total Assets by Year
Revelation Biosciences, Inc. Warrant closed fiscal year 2025 with $11.6M in total assets, $2.7M in total liabilities and $8.9M in shareholder equity. Total assets rose 74.9% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Revelation Biosciences, Inc. Warrant has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
REVBW Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K |
|---|---|---|---|---|---|---|---|
| Total Assets | $11.6M+74.9% | $6.6M-45.8% | $12.2M+121.9% | $5.5M+169.5% | $2.0M-97.2% | $74.2M+327023.7% | $23K |
| Total Liabilities | $2.7M+42.2% | $1.9M-65.6% | $5.6M+25.0% | $4.5M+107.8% | $2.1M-97.0% | $70.8M+268821.6% | $26K |
| Total Equity | $8.9M+88.2% | $4.7M-29.2% | $6.6M+531.6% | $1.1Mn/m | -$99K-102.9% | $3.4Mn/m | -$4K |
REVBW Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $10.0M-22.0% | $12.5M+131.7% | $15.0M+278.9% | $11.6M+74.9% | $12.9M+90.7% | $5.4M-56.0% | $4.0M-73.0% | $6.6M-45.8% | $6.7M-52.6% | $12.3M-23.5% | $14.7M-18.9% | $12.2M+121.9% |
| Total Liabilities | $2.8M+50.4% | $2.4M+54.9% | $2.1M+88.6% | $2.7M+42.2% | $1.9M-54.4% | $1.6M-85.9% | $1.1M-79.2% | $1.9M-65.6% | $4.1M-24.7% | $11.1M+140.7% | $5.2M-35.5% | $5.6M+25.0% |
| Total Equity | $7.2M-34.3% | $10.1M+163.1% | $13.0M+350.9% | $8.9M+88.2% | $11.0M+311.5% | $3.8M+235.5% | $2.9M-69.6% | $4.7M-29.2% | $2.7M-69.7% | $1.1M-90.0% | $9.5M-5.4% | $6.6M+531.6% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Revelation Biosciences, Inc. Warrant financials
Frequently Asked Questions
Revelation Biosciences, Inc. Warrant closed fiscal year 2025 with $11.6M in total assets, $2.7M in total liabilities and $8.9M in shareholder equity.
Revelation Biosciences, Inc. Warrant (REVBW) total assets rose by 74.9% year over year, from $6.6M to $11.6M in fiscal year 2025.
Across the 7 fiscal years this page covers, Revelation Biosciences, Inc. Warrant (REVBW) total assets went from $23K in fiscal year 2019 to $11.6M in fiscal year 2025.
Revelation Biosciences, Inc. Warrant (REVBW) reported $10.0M in total assets in Q3 2026. This represents a decrease of 22.0% from the same quarter a year earlier.
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Revelation Biosciences, Inc. Warrant (REVBW) reported on that line in every period on record.